Trials / Completed
CompletedNCT03385265
Iterative Beta Testing of Videos for the DIPPer Academy
An Interactive mHealth App for Better Glycemic Control in Parents of Young Kids With T1D
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- University of Kansas Medical Center · Academic / Other
- Sex
- All
- Age
- 3 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research is to develop DIPPer Academy, a parent-focused, mobile health (mHealth) behavioral intervention to promote glycemic control in young children.
Detailed description
Because many young children with T1D have glucose levels that exceed targets, investigators need to develop efficacious, accessible, and readily disseminable interventions to help them to improve their glycemic control. To do this, the investigators need efficacious interventions that specifically address the challenges that parents of young children face in daily T1D management. Providers need mHealth interventions that minimize barriers that parents experience when trying to access face-to-face or in clinic interventions. Finally, interventions are needed that are packaged to be easily deployable by other diabetes centers. The investigator's proposed intervention, DIPPer Academy, will include all of these recommended advancements.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | DIPPer Academy | The DIPPer Academy curricula will build on treatment models guided by the Health Beliefs Model (HBM) and Social Cognitive Theory (SCT). The curricula includes video microlectures, personalize progress reports, and other features delivered via the internet. |
| OTHER | Standard of Care | Parents in the standard of care control group will be instructed to manage their child's T1D as recommended by the diabetes team. |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2021-07-29
- Completion
- 2021-09-01
- First posted
- 2017-12-28
- Last updated
- 2022-03-11
- Results posted
- 2022-03-11
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03385265. Inclusion in this directory is not an endorsement.